AEON Biopharma, Inc. announced the approval of a 1-for-72 reverse stock split by its Board of Directors to comply with NYSE American listing requirements. This split will take effect on February 26, ...
(RTTNews) - AEON Biopharma, Inc. (AEON), a clinical-stage biopharmaceutical company, announced that its Board of Directors has approved a 1-for-72 reverse stock split of its common stock, effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results